The DOI matches its Crossref record.
Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.
Abstract
The molecular basis of familial chylomicronemia (type I hyperlipoproteinemia), a rare autosomal recessive trait, was investigated in six unrelated individuals (five of Spanish descent and one of Northern European extraction). DNA amplification by polymerase chain reaction (PCR) followed by single strand conformation polymorphism (SSCP) analysis allowed rapid identification of the underlying mutations. Six different mutant alleles (three of which are previously undescribed) of the gene encoding lipoprotein lipase (LPL) were discovered in the five LPL-deficient patients. These included an 11 bp deletion in exon 2, and five missense mutations: Trp 86 Arg (exon 3), His 136 Arg (exon 4), Gly 188 Glu (exon 5), Ile 194 Thr (exon 5), and Ile 205 Ser (exon 5). The Trp 86 Arg mutation is the only known missense mutation in exon 3. The other missense mutations lie in the highly conserved "central homology region" in close proximity with the catalytic site of LPL. These and other previously reported missense mutations provide insight into structure/function relationships in the lipase family. The missense mutations point to the important role of particular highly conserved helices and beta-strands in proper folding of the LPL molecule, and of certain connecting loops in the catalytic process. A nonsense mutation (Arg 19 Term) in the gene encoding apolipoprotein C-II (apoC-II), the cofactor of LPL, was found to underlie chylomicronemia in the sixth patient who had normal LPL but was apoC-…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Humans deficient in LPL manifest severe hypertriglyceridemia due to the lack of triglyceride clearing (11).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [11]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 35
- Cheng, 1981, Binding of lipoprotein lipase to endothelial cells in culture, J. Biol. Chem., 256, 12893, 10.1016/S0021-9258(18)42980-8 · DOI
- Cupp, 1987, Heparin decreases the degradation rate of lipoprotein lipase in adipocytes, J. Biol. Chem., 262, 6383, 10.1016/S0021-9258(18)45581-0 · DOI
- Olivecrona, 1990, Lipases involved in lipid metabolism, Curr. Opinion Lipidol., 1, 116, 10.1097/00041433-199004000-00006 · DOI
- Wion, 1987, Human lipoprotein lipase complementary DNA sequence, Science., 235, 1638, 10.1126/science.3823907 · DOI
- Deeb, 1989, Structure of the human lipoprotein lipase gene, Biochemistry., 28, 4131, 10.1021/bi00436a001 · DOI
- Kirchgessner, 1989, Organization of the human lipoprotein lipase gene and evolution of the lipase gene family, Proc. Natl. Acad. Sci. USA., 86, 9647, 10.1073/pnas.86.24.9647 · DOI
- Sparkes, 1987, Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p 22 and hepatic lipase to 15q21, Genomics., 1, 138, 10.1016/0888-7543(87)90005-X · DOI
- Xiong, 1991, No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles, Am. J. Hum. Genet., 48, 383
- Wilson, 1990, Pheno-typic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation, J. Clin. Invest., 86, 735, 10.1172/JCI114770 · DOI
- Babirak, 1989, The detection and characterization of the heterozygous state for lipoprotein lipase deficiency, Arteriosclerosis., 9, 326, 10.1161/01.ATV.9.3.326 · DOI
- Langlois, 1989, A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency, Proc. Natl. Acad. Sci. USA., 86, 948, 10.1073/pnas.86.3.948 · DOI
- Devlin, 1990, Partial gene duplication involving exon-alu interchange results in lipoprotein lipase deficiency, Am. J. Hum Genet., 46, 112
- Emi, 1990, Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene, Am. J. Hum. Genet., 47, 101
- Emi, 1990, Mis-sense mutation (Gly→Glu188) of the human lipoprotein lipase imparting functional deficiency, J. Biol. Chem., 256, 5910, 10.1016/S0021-9258(19)39449-9 · DOI
- Monsalve, 1990, A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries, J. Clin. Invest., 86, 728, 10.1172/JCI114769 · DOI
- Paulweber, 1991, Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia, Atherosclerosis., 86, 239, 10.1016/0021-9150(91)90220-W · DOI
- Ameis, 1991, Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene, J. Clin. Invest., 87, 1165, 10.1172/JCI115114 · DOI
- Ma, 1991, A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians, N. Engl. J. Med., 329, 1761, 10.1056/NEJM199106203242502 · DOI
- Faustinella, 1991, Catalytic triad residue mutation (Aspl56→Gly) causing familial lipoprotein lipase deficiency: co-inheritance with a nonsense mutation (Ser447→Ter) in a Turkish family, J. Biol. Chem., 266, 14418, 10.1016/S0021-9258(18)98701-6 · DOI
- Beg, 1990, Lipoprotein lipaseBethesda: a single ami no acid substitution (Alal76→Thr) leads to abnormal binding and loss of enzymatic activity, Proc. Natl. Acad. Sci. USA., 87, 3474, 10.1073/pnas.87.9.3474 · DOI
- Henderson, 1991, Ami no acid substitution (Ile194→Thr) in exon 5 of the lipoprotein lipase gene, J. Clin. Invest., 87, 2005, 10.1172/JCI115229 · DOI
- Dichek, 1991, Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome, J. Biol. Chem., 266, 473, 10.1016/S0021-9258(18)52459-5 · DOI
- Ma, 1992, Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase, J. Biol. Chem., 267, 1918, 10.1016/S0021-9258(18)46034-6 · DOI
- Iverius, 1985, Adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme, Am. J. Physiol., 249, E107
- Brunzell, 1983, Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase deficiency, J. Lipid Res., 24, 12, 10.1016/S0022-2275(20)38019-6 · DOI
- Cawthon, 1990, A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations, Cell., 62, 193, 10.1016/0092-8674(90)90253-B · DOI
- Orita, 1989, Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction, Genomics., 5, 874, 10.1016/0888-7543(89)90129-8 · DOI
- Orita, 1989, Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms, Proc. Natl. Acad. Sci. USA., 86, 2766, 10.1073/pnas.86.8.2766 · DOI
- Mullis, 1987, Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction, Methods Enzymol., 155, 335, 10.1016/0076-6879(87)55023-6 · DOI
- Sanger, 1977, DNA sequencing with the chain-terminating inhibitors, Proc. Natl. Acad. Sci. USA., 74, 5463, 10.1073/pnas.74.12.5463 · DOI · Paper page
- Persson, 1989, Structural features of lipoprotein lipase. Lipase family relationships, binding interactions, non-equivalence of lipase cofactors, vitellogenin similarities, and functional subdivision of lipoprotein lipase, Eur. J. Biochem., 179, 39, 10.1111/j.1432-1033.1989.tb14518.x · DOI
- Winkler, 1990, Structure of human pancreatic lipase, Nature., 343, 771, 10.1038/343771a0 · DOI
- Datta, 1988, Human hepatic lipase cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization and evolutionary relationships with lipoprotein lipase and pancreatic lipase, J. Biol. Chem., 263, 1107, 10.1016/S0021-9258(19)57271-4 · DOI
- Derewenda, 1991, Effects of gene mutations in the lipoprotein and hepatic lipases as interpreted by a molecular model of the pancreatic triglyceride lipase, J. Biol. Chem., 266, 23112, 10.1016/S0021-9258(18)54470-7 · DOI
- Gotoda, 1991, Heterogeneous mutations in the lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency, J. Clin. Invest., 88, 1856, 10.1172/JCI115507 · DOI
Cited by
Sorted by citations
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
Hegele, R. A., Berberich, A. J., Ban, M. R., Wang, J., Digenio, A., Alexander, V. J., D'Erasmo, L., Arca, M., Jones, A., Bruckert, E., et al. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.03.093 · Cited by 165
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Köbberling Type of Familial Partial Lipodystrophy
Herbst, K. L., Tannock, L. R., Deeb, S. S., Purnell, J. Q., Brunzell, J. D., & Chait, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1819 · Cited by 119
Self-citationNakou, E. S., Filippatos, T. D., Agouridis, A. P., Kostara, C., Bairaktari, E. T., & Elisaf, M. S. (2010) · Lipids · doi:10.1007/s11745-010-3409-0 · Cited by 23
Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance
Laakso, M., Malkki, M., Kek�l�inen, P., Kuusisto, J., & Deeb, S. S. (1995) · Diabetologia · doi:10.1007/s001250050328 · Cited by 22
Self-citation
Metadata
- Authors
- Reina, M., Brunzell, J., & Deeb, S.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1992-12
- Volume
- 33
- Issue
- 12
- Pages
- 1823-1832
- ISSN
- 0022-2275
- Cited by
- 74
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review